To develop an alternative shorter and potentially safer approach to primaquine dosing in G6PD deficiency, we conducted a two-part adaptive pharmacometric study in Thailand with the goal of characterising the dose-response relationship for primaquine-induced haemolysis in healthy G6PD-deficient volunteers. The gene discussed is G6PD; the disease is G6PD deficiency.